News

Sample size, patient selection keys to successful small studies


 

EXPERT ANALYSIS FROM 2014 ADVANCES IN IBD

References

Dr. Korzenik urged young investigators not to be intimidated, and to see their inexperience as liberation from having preconceived notions of what the correct approaches are to studying IBD. Still, finding a mentor “who can help shape your ideas and help develop techniques,” can be confidence building.

“You don’t necessarily need to have a final piece of work that can stand on its own,” Dr. Korzenik concluded. “You’re learning how to do a clinical trial and get your career moving forward.”

wmcknight@frontlinemedcom.com

On Twitter @whitneymcknight

Pages

Recommended Reading

Clinical factors associated with IBD can increase risk of CMV disease
MDedge Internal Medicine
Identification of subtypes, mutations in CRC and colon cancer greatly increases survival rates
MDedge Internal Medicine
Visible light spectrography should be used in diagnosing chronic gastrointestinal ischemia
MDedge Internal Medicine
Sofosbuvir and ribavirin critical to preventing posttransplantation HCV recurrence
MDedge Internal Medicine
FDA approves four-drug combination for HCV
MDedge Internal Medicine
HCV continuum critical to providing better care in urban areas
MDedge Internal Medicine
Rx for specialists: Know how ACA affects patients’ ability to pay for meds
MDedge Internal Medicine
FDA approves IV antibacterial for complicated UTIs, abdominal infections
MDedge Internal Medicine
New drugs are ‘nice’ but many IBD questions remain open for study
MDedge Internal Medicine
Gilead’s hepatitis C drugs to be sold exclusively at CVS
MDedge Internal Medicine